Abbott MediaRoom http://abbott.mediaroom.com/ Global Healthcare Organizations Join Abbott to Launch the UNIVANTS of Healthcare Excellence Award http://abbott.mediaroom.com/2018-08-03-Global-Healthcare-Organizations-Join-Abbott-to-Launch-the-UNIVANTS-of-Healthcare-Excellence-Award Global recognition for cross-functional care teams achieving measurably better healthcare Fri, 03 Aug 2018 17:12:00 -0400 http://abbott.mediaroom.com/2018-08-03-Global-Healthcare-Organizations-Join-Abbott-to-Launch-the-UNIVANTS-of-Healthcare-Excellence-Award Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling http://abbott.mediaroom.com/2018-08-02-Abbott-Expands-its-Directional-Deep-Brain-Stimulation-Therapy-by-Offering-New-MR-Conditional-Labeling - FDA approval of new software upgrade for Abbott's deep brain stimulation therapy enables advanced, patient-centric features for people living with Parkinson's disease and essential tremor Thu, 02 Aug 2018 09:00:00 -0400 http://abbott.mediaroom.com/2018-08-02-Abbott-Expands-its-Directional-Deep-Brain-Stimulation-Therapy-by-Offering-New-MR-Conditional-Labeling Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S. http://abbott.mediaroom.com/2018-07-27-Abbotts-FreeStyle-R-Libre-14-Day-Flash-Glucose-Monitoring-System-Now-Approved-in-U-S - ALLOWS USERS TO WEAR THE SENSOR FOR UP TO 14 DAYS WITH HIGH ACCURACY Fri, 27 Jul 2018 13:00:00 -0400 http://abbott.mediaroom.com/2018-07-27-Abbotts-FreeStyle-R-Libre-14-Day-Flash-Glucose-Monitoring-System-Now-Approved-in-U-S Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease http://abbott.mediaroom.com/2018-07-26-Abbott-Begins-U-S-Pivotal-Trial-for-the-Tendyne-Mitral-Valve-Replacement-System-to-Treat-Patients-with-Heart-Valve-Disease - Investigational Tendyne device is first and only repositionable and fully retrievable mitral valve replacement Thu, 26 Jul 2018 09:00:00 -0400 http://abbott.mediaroom.com/2018-07-26-Abbott-Begins-U-S-Pivotal-Trial-for-the-Tendyne-Mitral-Valve-Replacement-System-to-Treat-Patients-with-Heart-Valve-Disease Abbott Introduces Breakthrough Point-of-Care Test, the m-PIMA™ HIV-1/2 Viral Load (VL), at AIDS 2018 Amsterdam http://abbott.mediaroom.com/2018-07-24-Abbott-Introduces-Breakthrough-Point-of-Care-Test-the-m-PIMA-TM-HIV-1-2-Viral-Load-VL-at-AIDS-2018-Amsterdam NEW POINT-OF-CARE DIAGNOSTIC SOLUTION AIMS TO MAKE EFFECTIVE CARE MORE ACCESSIBLE FOR MILLIONS OF HIV PATIENTS, CONSISTENT WITH UNAIDS’ 90-90-90 GOALS Tue, 24 Jul 2018 09:00:00 -0400 http://abbott.mediaroom.com/2018-07-24-Abbott-Introduces-Breakthrough-Point-of-Care-Test-the-m-PIMA-TM-HIV-1-2-Viral-Load-VL-at-AIDS-2018-Amsterdam